Global Market Direct’s pharmaceuticals report, “Neorphys - Product Pipeline Review - 2013” provides data on the Neorphys’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Neorphys’s corporate website, SEC filings, investor presentations and featured press releases, both from Neorphys and industry-specific third party sources, put together by Global Markets Direct’s team.
- Neorphys - Brief Neorphys overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Neorphys human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Neorphys with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Neorphys’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate Neorphys’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Neorphys in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Neorphys’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Neorphys. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Neorphys and identify potential opportunities in those areas.
Table Of Contents
Neorphys - Product Pipeline Review - 2013 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Neorphys Snapshot 4 Neorphys Overview 4 Key Information 4 Key Facts 4 Neorphys - Research and Development Overview 5 Key Therapeutic Areas 5 Neorphys - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Neorphys - Pipeline Products Glance 9 Neorphys - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Discovery Products/Combination Treatment Modalities 10 Neorphys - Drug Profiles 11 Neo-1507 11 Product Description 11 Mechanism of Action 11 RandD Progress 11 Neo-1509 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 Neo-1528 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 Neo-15xx 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 Neorphys - Pipeline Analysis 15 Neorphys - Pipeline Products by Therapeutic Class 15 Neorphys - Pipeline Products by Target 16 Neorphys - Pipeline Products by Route of Administration 17 Neorphys - Pipeline Products by Molecule Type 18 Neorphys - Pipeline Products by Mechanism of Action 19 Neorphys - Dormant Projects 20 Neorphys - Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 23 Disclaimer 23
List of Tables
Neorphys, Key Information 4 Neorphys, Key Facts 4 Neorphys - Pipeline by Indication, 2013 6 Neorphys - Pipeline by Stage of Development, 2013 7 Neorphys - Monotherapy Products in Pipeline, 2013 8 Neorphys - Preclinical, 2013 9 Neorphys - Discovery, 2013 10 Neorphys - Pipeline by Therapeutic Class, 2013 15 Neorphys - Pipeline by Target, 2013 16 Neorphys - Pipeline by Route of Administration, 2013 17 Neorphys - Pipeline by Molecule Type, 2013 18 Neorphys - Pipeline Products by Mechanism of Action, 2013 19 Neorphys - Dormant Developmental Projects,2013 20
List of Figures
Neorphys - Pipeline by Top 10 Indication, 2013 6 Neorphys - Pipeline by Stage of Development, 2013 7 Neorphys - Monotherapy Products in Pipeline, 2013 8 Neorphys - Pipeline by Top 10 Therapeutic Class, 2013 15 Neorphys - Pipeline by Top 10 Target, 2013 16 Neorphys - Pipeline by Top 10 Route of Administration, 2013 17 Neorphys - Pipeline by Top 10 Molecule Type, 2013 18 Neorphys - Pipeline Products by Top 10 Mechanism of Action, 2013 19